Tim Iveson
Contact & Appointment


Professor Tim Iveson MD, FRCP

    Consultant Medical Oncolgist

Tim Iveson Oncologist

Clinical Interests

I specialise in the chemotherapy treatment of all gastro-intestinal cancers. Each patient is considered as an individual and their treatment is tailored according to their diagnosis and their fitness to receive treatment.

For cancers of the oesophagus (gullet) and stomach patients may need chemotherapy treatment (neoadjuvant therapy) prior to surgery or chemotherapy for advanced (metastatic) disease.

For cancers of the pancreas patients may need chemotherapy prior to surgery (neoadjuvant therapy), following surgery (adjuvant therapy) or chemotherapy for advanced (metastatic) disease.

For cancers of the colon and rectum (bowel cancer) patients may need chemotherapy following surgery (adjuvant therapy) or chemotherapy for advanced (metastatic disease). In certain circumstances some patients may need chemotherapy treatment prior to surgery (neoadjuvant therapy).

For Cancers of unknown primary (CUP) I investigate patients to try to identify a primary site of their disease and advise appropriate chemotherapy treatment.

I am involved in clinical trials investigating new treatments for gastro-intestinal cancers so I am up-to-date with all new treatments. I sit on two Trial Management Committees and two Trial Steering Committees (one of which I chair). I have chaired two Independent Data Monitoring Committee for global studies of Ramucirumab in the treatment of gastric cancer.

I am the Chief Investigator of the SCOT study looking at the duration of adjuvant chemotherapy for colorectal cancer and am a member of the IDEA (International Duration Evaluation of Adjuvant Chemotherapy) Steering Committee, which is undertaking a meta-analysis of 6 studies all looking at duration of adjuvant chemotherapy treatment. The work has been practice changing globally reducing the duration of adjuvant chemotherapy for many patients and resulting in fewer side-effects.

I have been a member of the NCRI (National Cancer Research Institute) Colorectal Cancer Adjuvant and Advanced Disease sub-group. I was a member of the NICE Colorectal Guidance Group, which drew up the NICE Colorectal guidelines and on the NICE Quality Standard Colorectal Cancer Topic Expert Group.

I believe that it is important that patients receive high quality information about their treatment. I am Chief Medical Editor for Macmillan and sit on their Expert Advisory Board. I am a member of the Bowel Cancer UK Medical advisory Board.

NHS Practice

University Hosital Southampton
Tremona Road
Hampshire, SO16 6YD
Tel: 023 8120 6802

Spire Southampton

Chalybeate Close
SO16 6UY
Jan Onoufriou
Tel: 023 8027 0956

New Hall Hospital

Wiltshire, SP5 4EY
Angela Iveson
Tel: 01725 513579